|
|
|
|
|
|
|
|
|
The New Economics of Biologics: Breaking the $50/g Barrier — Now
|
When does process intensification become the stronger economic choice for mAb manufacturing? The answer depends on production volume, titer, facility utilization, and process configuration. In our new report, modeling results show how different manufacturing scenarios influence cost of goods — and where intensified single-use and continuous approaches can support costs below $50/g. Read the report to explore the economics behind the next generation of biologics manufacturing.
|
|
|
|
|
|
Video | Thermo Fisher Scientific Bioproduction
|
Streamline and customize your cell processing workflow with automated, precise control over fluid movement and transfer parameters.
|
|
|
|
|
|
Video | Bioprocess Online
|
In this opening segment from the Bioprocess Online Live event, panelists David Scherr, Ph.D. (AstraZeneca) and Vadim Klyushnichenko, Ph.D. (Calibr-Skaggs), discuss what metrics matter the most to evaluate productivity and measure process performance.
|
|
|
|
|
|
Webinar | Grand River Aseptic Manufacturing
|
Explore how adaptable technologies and strategic partnerships help navigate Annex 1 compliance and technical hurdles to ensure the successful delivery of complex drug products.
|
|
|
|
|
|
Webinar | Miltenyi Biotec
|
Gain practical insight into building scalable stem cell manufacturing processes while maintaining consistency and quality across workflows, as well as in-depth guidance to support your strategy.
|
|
|
|
|
|
Video | AGC Biologics
|
Maggie Chen, Senior Director, Manufacturing & MSAT, discusses the importance of maintaining relationships throughout the project timeline as well as how to move to the standardization approach.
|
|
|
|
|
|
Webinar | Cytiva
|
See how AI-driven tools and optimized platforms are accelerating biologics development, delivering high-titer clones in weeks, and paving the way for integrated design of cell lines and genetic systems.
|
|
|
| Connect With Bioprocess Online: |
|
|
|
|
